EEF2K and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K)